Table 3.

Adjusted clinical and utilisation outcomes over 12-month follow-up

	Adjusted OR* (95% CI)
Adjusted clinical outcomes over 12 months of follow-up
Implantable loop recorder
New atrial fibrillation diagnosis	1.89 (1.76 to 2.02)
New atrial fibrillation diagnosis and anticoagulant initiation	2.27 (2.09 to 2.48)
Haemorrhagic stroke	1.60 (1.34 to 1.93)
Major gastrointestinal bleeding	1.02 (0.91 to 1.14)
Other major bleeding	1.11 (0.84 to 1.46)
Other minor bleeding	1.06 (0.97 to 1.16)
Holter monitor
New atrial fibrillation diagnosis	0.57 (0.52 to 0.62)
New atrial fibrillation diagnosis and anticoagulant initiation	0.54 (0.48 to 0.62)
Haemorrhagic stroke	0.87 (0.70 to 1.08)
Major gastrointestinal bleeding	1.04 (0.94 to 1.16)
Other major bleeding	0.71 (0.51 to 0.97)
Other minor bleeding	1.10 (1.01 to 1.19)
Adjusted utilisation outcomes over 12 months of follow-up
Implantable loop recorder
All-cause acute inpatient	1.13 (1.06 to 1.21)
All-cause emergency department	1.04 (0.99 to 1.10)
Holter monitor
All-cause acute inpatient	0.99 (0.93 to 1.05)
All-cause emergency department	0.93 (0.88 to 0.98)

The reference group for all models is the long-term external continuous cardiac monitor (>48 hours to 30 days) group.

*All models adjusted for CHA₂DS₂-VASc score.